HomeSNDX • NASDAQ
add
Syndax Pharmaceuticals Inc
Previous close
$8.95
Day range
$8.80 - $9.15
Year range
$8.58 - $25.06
Market cap
778.73M USD
Avg Volume
2.47M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Revenue | 20.04M | — |
Operating expense | 102.67M | 29.12% |
Net income | -84.85M | -17.19% |
Net profit margin | -423.34 | — |
Earnings per share | -0.98 | -15.29% |
EBITDA | -83.51M | -5.03% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 516.31M | 16.51% |
Total assets | 640.71M | 17.99% |
Total liabilities | 425.65M | 732.34% |
Total equity | 215.06M | — |
Shares outstanding | 86.05M | — |
Price to book | 3.58 | — |
Return on assets | -30.58% | — |
Return on capital | -34.95% | — |
Cash Flow
Net change in cash
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Net income | -84.85M | -17.19% |
Cash from operations | -95.16M | -13.90% |
Cash from investing | 94.14M | 194.71% |
Cash from financing | 930.00K | -57.10% |
Net change in cash | -90.00K | 99.95% |
Free cash flow | -69.96M | -25.90% |
About
Founded
2005
Website
Employees
270
